Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131329) titled 'A Study on the Efficacy and Safety of rhTPO in the Treatment and Prevention of CTIT in Children with Solid Tumors' on Sept. 1.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: West China Second University Hospital, Sichuan University
Condition:
Pediatric cancer treatment-induced thrombocytopenia, CTIT
Intervention:
Treatment group:For patients who develop CTIT with a platelet count =50 x 10^9/L compared to the pre-treatment level, while also excluding the receipt of platelet transfusion within 2 days.
Prevention group:For study participants with high-risk factors for ...